Axsome Therapeutics (AXSM) PT Raised to $300 at B.Riley

May 5, 2026 4:20 AM

B.Riley analyst Madison El-Saadi raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $300.00 (from $230.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found